J&J Innovative Medicine

**Janssen Pharmaceuticals** is a pioneering branch of the Johnson & Johnson family, committed to transforming healthcare by leveraging science and creativity to redefine the future of medicine. With a mission to eradicate disease, Janssen focuses on critical therapeutic areas including Cardiovascular, Immunology, Infectious Diseases and Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. The company has assembled a global team of 40,000 dedicated professionals who strive daily to develop innovative treatments and improve patient care.

Janssen is not only engaged in research and development but also emphasizes partnerships across the healthcare landscape to enhance access to their transformative medicines. They actively involve patients and caregivers in the development process, ensuring that their needs and experiences shape the solutions offered. Through a rich pipeline of research, Janssen is committed to addressing significant health challenges with new and effective therapies, ultimately working towards a future where diseases are merely a memory.